Delivery Order SPE2DB24D9113-SPE2DB25FEQBE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $22,365.06 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit 6ML, with an ultimate completion date of October 7, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this work at its Park Ridge facility. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under the company's...
- The Defense Logistics Agency has awarded a delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Photrexa Cross-Linking Kit 6ml. This delivery order, issued on August 22, 2025, carries a firm fixed price and an ultimate completion date of September 15, 2025. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of PHOTREXA Cross-Linking Kit in 6ml quantities. The contract is valued at $14,910.04 under a firm fixed-price arrangement with an ultimate completion date of June 25, 2025. This delivery order was issued without set-aside designation and represents a continuation of DMS Pharmaceutical Group's significant role...
- The Defense Logistics Agency awarded a delivery order valued at $14,910.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit in 6ml units. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a discrete task order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The company...
- The Defense Logistics Agency awarded a $18,637.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 3, 2025, for the supply of Photrexa Cross-Linking Kit 6ML, with an ultimate completion date of September 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The company will perform this delivery order at its Park Ridge, IL location, continuing its...
- The Defense Logistics Agency awarded a delivery order valued at $7,455.02 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit in 6ml quantities. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and was awarded on August 15, 2025 without a set-aside designation. The delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,727.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-linking Kit 6ML. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, represents a discrete purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The award carries...
- The Defense Logistics Agency (DLA) awarded a $7,455.02 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of a Photrexa Cross-Linking Kit (6ml). This firm fixed-price delivery order, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, carries no set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit (6ml). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its Park Ridge facility, with an ultimate completion date of September 24, 2025. This delivery order was issued without a set-aside designation and represents one of many...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and was awarded on September 9, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- SPE2DB24D9113Indefinite Delivery Contract
- SPE2DB24D9113-SPE2DB25FEQBEDelivery Order
The Defense Logistics Agency awarded a $14.9 million delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. Issued on June 18, 2025, with an ultimate completion date of July 11, 2025, this firm fixed-price delivery order carries no set-aside designation. The award is structured as a delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at $500 million through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and specialized medical consumables to military health systems nationwide. The company's extensive portfolio of federal contracts demonstrates its capacity to supply diverse pharmaceutical products across multiple therapeutic categories. This delivery order for Photrexa, a corneal cross-linking treatment used in ophthalmology, reflects the company's role in supporting the medical supply needs of the Department of Defense and its continued position as a preferred vendor for pharmaceutical distribution under the Defense Logistics Agency's SPE2DB program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 6/18/25 |